
Let's explore the future of diagnostics together
Why should you attend?
icon-cta-blockquote2
Message from Davide Manissero, Chief Medical Officer, Medical and Scientific Affairs, QIAGEN:
“The last year and a half has been an exceptionally challenging and tumultuous time for microbiology laboratories and healthcare providers around the world, and COVID-19 has highlighted the need for more rapid and sensitive methods of molecular diagnostic testing. We hope this event will provide a forum for individuals in infectious diseases diagnostics to come together as we navigate an unprecedented respiratory season ahead.”
Program at glance
Wednesday, December 8, 2021 | |
---|---|
5:00 p.m. CET (8:00 a.m. PST) |
Welcome and introduction Davide Manissero, MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN |
5:05 p.m. CET |
Multiplex PCR for the diagnostic evaluation of gastrointestinal infections Prof Dr med Stephan Gehring, Department of Pediatrics, Children’s Hospital Universitätsmedizin Mainz, Germany |
5:35 p.m. CET |
Looking into the crystal ball: What will influenza-like illness season potentially look like post-COVID-19 pandemic Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine, MD Anderson Cancer Center, USA |
6:05 p.m. CET |
Respiratory syndromic testing for pediatrics – over-priced surveillance or thorough diagnostic evaluation? Susan A. Weaver, PhD, CLS, Clinical and Anatomic Laboratory Director, Natividad Medical Center, USA |
6:35 p.m. CET |
Panel discussion Host: Davide Manissero MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN Panelists:
|